[Immunological and nonspecific reactivity in patients with infiltrative pulmonary tuberculosis associated with chronic nonspecific lung diseases].
Morozova. T I TI; Khudzik. L B LB; Rebrov. A P AP
Key Findings
- TB patients showed weakened cellular and humoral immunity, complement activity, and lower levels of protease inhibitors
- Aerosol thymalin combined with protease inhibitors improved these immune parameters
- The combined treatment enhanced the effectiveness of standard TB therapy
Practical Outcomes
- For biohackers, thymalin may have modest immune‑supporting properties, but the evidence is from a specific disease setting. It suggests potential benefit as an adjunct for immune health, yet more research is needed before recommending routine use for longevity or performance.
Summary
The study found that giving patients with lung tuberculosis an aerosol spray containing the peptide thymalin (along with other protease inhibitors) helped improve their immune system markers and supported the main TB treatment, but the research is limited to sick patients and not directly aimed at healthy people looking to boost performance.
Abstract
When examined for immunological status, complement, basic endogenic protease blockers parameters, patients with infiltrative destructive tuberculosis of the lungs (IDTL) and IDTL combination with exacerbation of chronic pyo-inflammatory bronchitis, exhibited disturbances in cellular and humoral immunity, complement activity, content of alpha 1 protease inhibitor and alpha 2 macroglobulin which aggravated in combined respiratory pathology. Nonspecific aerosol treatment with native protease inhibitors (contrykal or gordox) and thymalin aroused the efficacy of etiotropic treatment and promoted normalization of the above defense systems.
Study Information
pubmed
1995